Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients.

Huang MY, Wang HM, Chang HJ, Hsiao CP, Wang JY, Lin SR.

DNA Cell Biol. 2012 Jan;31(1):43-9. doi: 10.1089/dna.2011.1264. Epub 2011 Oct 19.

2.

EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patients.

Huang MY, Wang HM, Tok TS, Chang HJ, Chang MS, Cheng TL, Wang JY, Lin SR.

DNA Cell Biol. 2012 Apr;31(4):625-35. doi: 10.1089/dna.2011.1365. Epub 2011 Nov 2.

PMID:
22047082
3.
4.

Clinical significance of osteoprotegerin expression in human colorectal cancer.

Tsukamoto S, Ishikawa T, Iida S, Ishiguro M, Mogushi K, Mizushima H, Uetake H, Tanaka H, Sugihara K.

Clin Cancer Res. 2011 Apr 15;17(8):2444-50. doi: 10.1158/1078-0432.CCR-10-2884. Epub 2011 Jan 26.

5.

Significant overexpression of DVL1 in Taiwanese colorectal cancer patients with liver metastasis.

Huang MY, Yen LC, Liu HC, Liu PP, Chung FY, Wang TN, Wang JY, Lin SR.

Int J Mol Sci. 2013 Oct 14;14(10):20492-507. doi: 10.3390/ijms141020492.

6.

Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.

Findeisen P, Röckel M, Nees M, Röder C, Kienle P, Von Knebel Doeberitz M, Kalthoff H, Neumaier M.

Int J Oncol. 2008 Nov;33(5):1001-10.

PMID:
18949363
7.

Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.

Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR.

PLoS One. 2011 Feb 24;6(2):e16636. doi: 10.1371/journal.pone.0016636.

8.

Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.

Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M.

Cancer Res. 2013 Apr 1;73(7):2059-69. doi: 10.1158/0008-5472.CAN-12-0326. Epub 2013 Feb 1.

9.

MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.

Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W.

Med Oncol. 2012 Jun;29(2):1037-43. doi: 10.1007/s12032-011-9975-z. Epub 2011 May 12.

PMID:
21562850
10.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
11.

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DS.

J Clin Oncol. 2005 Apr 20;23(12):2744-53.

PMID:
15837989
12.

Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.

Sato T, Oshima T, Yoshihara K, Yamamoto N, Yamada R, Nagano Y, Fujii S, Kunisaki C, Shiozawa M, Akaike M, Rino Y, Tanaka K, Masuda M, Imada T.

Oncol Rep. 2009 Jan;21(1):211-6.

PMID:
19082464
13.

Whole genome analysis for liver metastasis gene signatures in colorectal cancer.

Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, Kim NK, Chung HC, Rha SY.

Int J Cancer. 2007 Nov 1;121(9):2005-12.

14.

Differential gene expression profile of MAGE family in taiwanese patients with colorectal cancer.

Chung FY, Cheng TL, Chang HJ, Chiu HH, Huang MY, Chang MS, Chen CC, Yang MJ, Wang JY, Lin SR.

J Surg Oncol. 2010 Aug 1;102(2):148-53. doi: 10.1002/jso.21580.

PMID:
20648585
15.

Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.

Stange DE, Engel F, Longerich T, Koo BK, Koch M, Delhomme N, Aigner M, Toedt G, Schirmacher P, Lichter P, Weitz J, Radlwimmer B.

Gut. 2010 Sep;59(9):1236-44. doi: 10.1136/gut.2009.195701. Epub 2010 May 17.

PMID:
20479215
17.

CC chemokine ligand 7 expression in liver metastasis of colorectal cancer.

Cho YB, Lee WY, Choi SJ, Kim J, Hong HK, Kim SH, Choi YL, Kim HC, Yun SH, Chun HK, Lee KU.

Oncol Rep. 2012 Aug;28(2):689-94. doi: 10.3892/or.2012.1815. Epub 2012 May 14.

PMID:
22614322
18.

FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer.

Ozawa H, Iwatsuki M, Mimori K, Sato T, Johansson F, Toh H, Watanabe M, Mori M.

Ann Surg Oncol. 2010 Sep;17(9):2341-8. doi: 10.1245/s10434-010-1002-7. Epub 2010 Mar 26.

PMID:
20339950
19.
20.

Significant overexpression of Hsp110 gene during colorectal cancer progression.

Slaby O, Sobkova K, Svoboda M, Garajova I, Fabian P, Hrstka R, Nenutil R, Sachlova M, Kocakova I, Michalek J, Smerdova T, Knoflickova D, Vyzula R.

Oncol Rep. 2009 May;21(5):1235-41.

PMID:
19360299

Supplemental Content

Support Center